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ARTICLE
Whole-exome sequencing in an isolated population
from the Dalmatian island of Vis
Ana Jeroncic*,1, Yasin Memari2, Graham RS Ritchie2, Audrey E Hendricks2,3, Anja Kolb-Kokocinski2,
Angela Matchan2, Veronique Vitart4, Caroline Hayward4, Ivana Kolcic5, Dominik Glodzik4, Alan F Wright4,
Igor Rudan6, Harry Campbell6, Richard Durbin2, Ozren Polašek5,6, Eleftheria Zeggini2 and Vesna Boraska Perica*,2,7
We have whole-exome sequenced 176 individuals from the isolated population of the island of Vis in Croatia in order to describe
exonic variation architecture. We found 290 577 single nucleotide variants (SNVs), 65% of which are singletons, low frequency
or rare variants. A total of 25 430 (9%) SNVs are novel, previously not catalogued in NHLBI GO Exome Sequencing Project,
UK10K-Generation Scotland, 1000Genomes Project, ExAC or NCBI Reference Assembly dbSNP. The majority of these variants
(76%) are singletons. Comparable to data obtained from UK10K-Generation Scotland that were sequenced and analysed using
the same protocols, we detected an enrichment of potentially damaging variants (non-synonymous and loss-of-function) in the
low frequency and common variant categories. On average 115 (range 93–140) genotypes with loss-of-function variants, 23
(15–34) of which were homozygous, were identiﬁed per person. The landscape of loss-of-function variants across an exome
revealed that variants mainly accumulated in genes on the xenobiotic-related pathways, of which majority coded for enzymes.
The frequency of loss-of-function variants was additionally increased in Vis runs of homozygosity regions where variants mainly
affected signalling pathways. This work conﬁrms the isolate status of Vis population by means of whole-exome sequence and
reveals the pattern of loss-of-function mutations, which resembles the trails of adaptive evolution that were found in other
species. By cataloguing the exomic variants and describing the allelic structure of the Vis population, this study will serve as a
valuable resource for future genetic studies of human diseases, population genetics and evolution in this population.
European Journal of Human Genetics advance online publication, 6 April 2016; doi:10.1038/ejhg.2016.23
INTRODUCTION
Recent advances in genotyping and sequencing technologies have
opened a route to a new dimension of population studies, enabling the
development of clear insight into the past of any population and
corroboration of existing evidence from the domains of palaeontology,
archaeology and historical evidence with unprecedented validation and
precision. This type of analysis is interesting not only on the global
scale,1 but also on a local scale, particularly in the case of special and
isolated populations. Such populations may retain their genetic
isolation and uniqueness due to a number of possible factors,
including geographical, ethnic or linguistic barriers, and have been
estimated to encompass over 11.5 million individuals in Europe
alone.2
The Croatian Adriatic islands are geographically isolated, habitat-
unique localities characterized by distinctive population histories,
which include varying founding times and consequent population
age, severe plague bottlenecks and massive waves of emigration due to
deteriorating economical conditions.3 The genetic structure was also
affected by historic events, such as near annihilation of the island
populations in the conﬂicts with the ancient Roman Empire, a shift
caused by the massive Slavs arrival in ~ 700 AD and clashes with the
Ottoman Empire.3–6 Genetic studies revealed a reduction of haplotype
diversity in Vis compared to an outbread population from Scotland
and presented a founder effect in Vis mtDNA sequences.7 Besides drift
and increased homogeneity, isolated populations also tend to harbour
unique rare variants,8 making them very useful tools in genetic
association studies.9 These properties have contributed to the devel-
opment of the 10 001 Dalmatians resource (http://www.mefst.hr/
default.aspx?id= 826), the largest research-oriented biobank in Croa-
tia, now commonly used in genetic studies worldwide.10
The aim of this study is to perform an exhaustive exploratory
analysis of the exomic structure of the modern-day population of the
island of Vis. By cataloguing exomic variants, investigating their
frequencies and functional effects, and examining autozygosity, we
describe the allelic architecture of this isolated population, providing
the basis for a valuable resource for future genetic studies focusing on
disease susceptibility, population genetics and evolution.
MATERIALS AND METHODS
Participant recruitment and sample collection
We conducted exome-wide sequencing of 193 individuals from the isolated
population of the island of Vis, Croatia. The sample for this study was based on
the initial cohort of 1026 participants, which were initially recruited in the
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CROATIA-Vis study (the 10 001 Dalmatians project) between 2003 and 2004.11
The participants were recruited on the basis of vital registries, postal invitations
and other means of invitations. In total, 193 participants (38% men) were
selected for the purpose of this study on the basis of three criteria. The ﬁrst
criterion was that a participant originated from the island of Vis, which was
veriﬁed by the Parish records that were reconstructed for the period of 1850
onwards, and later corroborated by the genealogical records provided by the
subjects. Second, we used the participants whose DNA was successfully
extracted and who were not identiﬁed as genetic outliers in the initial
CROATIA-Vis study by principal components analysis of genome-wide,
Illumina HumanHap300 (San Diego, CA, USA) genotypes. Last, we used
ANCHAP, a method for detecting identity by descent in isolated populations,
to select a sample of participants which maximised the whole sample
haplotypes representation.7 Mean genomic kinship of the sample was 0.002,
as estimated by the KING algorithm.
All subjects were asked to provide written consent, after being informed on
the study goals and main approaches, in accordance with the Declaration
of Helsinki. The study was approved by the ethics committees of the University
of Zagreb (No. 018057) and the University of Split School of Medicine
(No. 2181-198-A3-04110-11-0008), Croatia and the Multi-Centre Research
Ethics Committee for Scotland (No. 01/0/71).
Exome capture and sequencing
Sequencing was performed at the Wellcome Trust Sanger Institute, Hinxton,
Cambridge, UK. The exomes were captured from blood genomic DNA, using
SureSelect Human All Exon SeqCap pulldown technology and were sequenced
with 75 bp paired-end reads on Illumina HiSeq platform according to
manufacturer’s protocol. The capture kit used for exome enrichment was
Agilent’s SureSelect Human All Exon 50 Mb (Agilent, Santa Clara, CA, USA),
targets 51.8 Mb of human genome by design and encompasses uniﬁed set of
coding exons annotated on August, 2010 by GENCODE or CCDS databases
(including 10 bp of ﬂanking sequence for each consensus coding DNA
sequence). The probe design also includes small non-coding RNA regions
annotated by miRBase v.13 (Manchester, UK) and Rfam (Hinxton, UK)
databases, and overall, reports a 100% breadth of coverage.
Compared to the CCDS database, the total of 653 828 probes tile to 97% of
targeted bases. If regions captured upstream and downstream of targets are
considered, the kit targets 90.5 Mb of genome, providing additionally a broad
coverage of non-coding DNA in exon-ﬂanking regions (promoters and
untranslated regions (UTRs)).
Variant calling and annotation
Details of the workﬂow used for single nucleotide variant (SNV) calling on the
exome data are given in Supplementary material. Called SNVs were annotated
with dbSNP137 rsIDs and 1000Genomes super population allele frequencies
that were extracted from the ﬁnal 1000Genomes Phase 1 integrated (v3) callset.
Functional annotations were called with the Ensembl Variant Effect Predictor
v2.8 against Ensembl 70, which provided coding consequence predictions and
SIFT, PolyPhen and Condel annotations as well as GERP conservation scores
(http://www.ensembl.org/info/docs/tools/vep/index.html).
The same calling and annotation protocol was also applied to the Generation
Scotland UK10K_OBESITY_GS whole-exome data, that was used for compar-
ison with Vis dataset (UK10K-GS—release 2012-11-27 variant dataset; after the
initial quality control dataset included n= 377 samples from Scotland
ascertained on the basis of body mass index (BMI)440 or pedigrees discordant
for BMI). Variants in the UK10K-GS dataset were generated by whole-exome
sequencing (WES) as part of the UK10K project that used the same targeted
regions, sequencing protocols and downstream bioinformatics pipeline as
our study.
The generated WES data have been submitted to the European Genome-
phenome Archive (https://www.ebi.ac.uk/ega/home) with the accession numbers
EGAS00001000336 and EGAD00001001387.
Performance of whole-exome sequencing
Sequencing depth and coverage of targeted regions were calculated using
Samtools’ 0.1.19 bamcheck (v2012-09-04, http://samtools.sourceforge.net).
We collected high-coverage exon-capture data for 193 samples with a median
of 99.9 (range, 71.6–170.1) million reads per subject, and median raw depth for
the SureSelect target regions of 110× . Median insert size across all samples was
181 (173–203) bp per sample. On average, 99.6% (99.2–99.7%) of
per subject reads were mapped to the human reference genome, with reads
in the target regions mapped to 100%. After removal of PCR duplicates, 90.7%
(84.8–93.8%) of per subject reads were retained. Among those uniquely
mapped, 85.1% (79.2–93.9%) of per subject reads were within the target
regions.
The median value of aligned-read depth on the target regions per subject was
110× (78–193) with 51.5 Mb (99.5% of target regions) covered by at least
30× , and 39.9 Mb (77.2%) covered by at least 50× . For sequences falling
outside the target but within the calling regions, 29.2 Mb (75.3% of out-target
calling region) were covered by at least 30× read and 15.6 Mb (40.2%) were
covered by at least 50× reads. The analysis of aggregate on target Ti/Tv ratio
implied that the calling pipeline produced a good quality variant callset
(Supplementary material, Ti/Tv ratio).
Standard sample and SNV quality controls were performed on the Vis and
the UK10K-GS multi-sample called exome-sequence datasets, and are described
in detail in Supplementary material. Close relatives were removed from both
samples based on pairwise identity by descent sharing. Only bi-allelic SNVs
were included in the study.
General description of Vis exome sequence
We examined the distribution of all SNVs according to internal, sample speciﬁc
allele frequency categories. We also examined the proportion of functional
effects in each allele frequency category. For description purposes we used the
most deleterious effect of the variant according to severity estimated by
Ensembl (http://www.ensembl.org/info/docs/variation/predicted_data.html).
For the data representation in the main text we have summarised Ensembl
consequence annotations into fewer categories (Supplementary Table 1).
We compared Vis exome data with the UK10K-GS WES dataset, NHLBI GO
Exome Sequencing Project (NHLBI) (http://evs.gs.washington.edu/EVS/), NCBI
Reference Assembly dbSNP (dbSNP) (http://www.ncbi.nlm.nih.gov/projects/
SNP/) as well as 1000Genomes (http://www.1000genomes.org/data#DataAvail-
able) and Exome Aggregation Consortium datasets (ExAC) (http://exac.broad-
institute.org/) in order to identify novel variants not reported in the reference
datasets. We uniquely identiﬁed variants using chromosome, base pair position
and an allele identity in each dataset before comparison. All variants were on
hg19, build37.
To calculate dN/dS ratios we determined the number of non-synonymous
(missense, stop_lost, stop_gained or initiator_codon variants) and synonymous
(synonymous and stop_retained variants) substitutions and adjusted the values
for multiple substitutions. Only substitutions within known protein-coding
DNA sequence were analysed.
Autozygosity was detected through runs of homozygosity (ROH) on a set of
common, independent SNVs. Owing to reduced SNV density in such
set (~50 k), only long ROHs (45 Mb) were analysed. Calls were made in
PLINK v1.07 (http://pngu.mgh.harvard.edu/Bpurcell/plink/) using parameters
optimised for detection of ROHs in WES sequences.12 ROH hotspots and
coldspots were identiﬁed if the SNP-wise ROH frequency was above or below
the 95%th percentile of the level of sharing, respectively.
Loss of function variants
SNVs predicted by the Ensembl Variant Effect Predictor as stop-gained
(nonsense) or splice site-disrupting (splice donor or acceptor) SNVs were
deﬁned as loss of function (LoF) variants. In total 1775 putative LoF variants
were obtained in Vis. Potential LoF variants that were likely due to reference
errors or annotation artefacts were ﬁltered. SNVs were marked as false positives
if the inferred LoF allele was also the ancestral state (73 SNVs in Vis and 115 in
UK10K-GS) indicating that a gain-of-function allele was the recent mutation
on a site. We also excluded LoF SNVs (24 in Vis and 17 in UK10K-GS) that
were identiﬁed as major allelic variant (MAF40.5) in our samples, and in all
super populations from the 1000Genomes project: European (EUR), Asian
(ASN), African (AFR), Ad Mixed American (AMR). At these sites the reference
genome differed from majority of analysed humans indicating a probable
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reference genome error. In example, at these sites we observed extremely high
frequency of homozygous LoF variants (0.26–0.89) (Supplementary Table 2).
After ﬁltering, there were 1678 remaining LoF variants in Vis, and 3149 in the
UK10K dataset.
The analysis of over-representation of Gene Ontology (GO) annotations
and the pathway analysis were performed on a set of genes containing LoF
variants using ConsensusPathDB-human database (http://consensuspathdb.org/).13
False discovery rate q-value of 0.1 and a P-value of 0.05 were used to identify
over-represented functional groups.
RESULTS
General description of Vis exome sequence
Overall, the performance of whole-exome sequencing with high
percentage of reads uniquely mapped to target regions, with aligned-
read depth on target regions of 110× , and 51.5 Mb (99.5%) of target
regions covered by at least 30× ; indicated efﬁcient targeted
sequencing.
We found 290 577 SNVs of which 65% were singletons, low
frequency or rare (Table 1, more detailed category deﬁnitions
are provided in Supplementary Table 3). Rare variants (MAF⩽ 0.01)
were the most prevalent in both LoF and nonsynonymous variants,
with the percentage of rare SNVs among LoF variants signiﬁcantly
outnumbering the corresponding percentage among nonsynoymous
SNVs. On contrary, the percentages of both low (0.01oMAF⩽ 0.05),
and common (MAF40.05) frequency variants among nonsynon-
ymous SNVs was signiﬁcantly higher than among LoF SNVs.
(Supplementary Figure 2a, 95% conﬁdence interval (CI)).
Relative to UK10K-GS, the Vis sample shows a depletion of rare
variants and excess of low frequency and common variants
(Supplementary Figure 2b). The comparison of potentially deleterious
variants (non-synonymous and LoF) showed the same pattern, that is,
a decrease of rare, and an excess of low and common frequency
variants in Vis (Supplementary Figure 2b). This difference was not the
consequence of different sample sizes. When we randomly re-sampled
(n= 100) the same number of individuals from each population and
compared allele frequencies of variants shared by both populations,
again a decrease in proportion of shared-rare variants (p 7.1 × 10− 27),
and increase in proportion of shared low-frequency variants
(p 7.0 × 10− 20) were observed in Vis (Supplementary Figure 2c).
Moreover, frequency of shared variants declared as rare or low
frequency in Vis was signiﬁcantly increased compared to the same
variants in UK10K-GS. Median difference in allele frequency per
shared variant was 0.0008 for rare and 0.003 for low-frequency
variants, which corresponds in both cases to 8% of the total frequency
range of particular frequency category (one sample U-test for median
of differences against zero, P⩽ 3.2 × 10− 20).
The majority of detected variants in Vis are intronic (45%)
(Figure 1; more detailed category deﬁnitions are provided in
Supplementary Figure 3) pointing out that our baits also captured
some of the intronic regions that surround exons. Intron SNVs were
positioned predominantly (83.3%) within 200 bp from the nearest
exon boundary with a median distance of 89 bp (interquartile range
53–132). If we exclude intronic regions then, consistently with
previous reports, non-synonymous variants are the most common,
followed by synonymous variants and of these the majority are
singletons and rare variants (Table 1). Aggregate site frequency spectra
by variant functional consequence are shown in Supplementary
Figure 4.
Table 1 The count of all variants, and completely novel variants in each functional effect group separated by allele frequency categories
Variant consequence annotations All variants Singletons Doubletons MAF⩽0.01 0.01oMAF⩽0.02 0.02oMAF⩽0.05 0.05oMAF⩽0.1 MAF40.1
All variants
Loss_of_function 1775 892 219 100 152 93 79 240
Non_synonymous 60 011 22939 6988 3626 6119 4834 3944 11 561
Splice_region 8748 2657 886 468 892 791 689 2365
Synonymous 44 582 12891 4292 2501 4491 4111 3658 12 638
UTR 17165 4945 1792 1073 1865 1585 1438 4467
ncRNA 23033 6292 2210 1256 2274 2190 2145 6666
Intronic 131 531 35463 13 016 7519 13797 12 426 11 828 37 482
Upstream 2056 506 206 118 204 181 209 632
Downstream 1142 265 108 63 105 114 131 356
Regulatory 73 13 8 5 8 5 11 23
Intergenic 461 106 28 18 43 38 50 178
Total 290 577 86969 29 753 16 747 29950 26 368 24 182 76 608
Completely novel variants
Loss_of_function 269 230 27 7 5 0 0 0
Non_synonymous 4783 3978 515 167 116 3 1 3
Splice_region 552 455 60 17 19 1 0 0
Synonymous 2141 1738 250 85 57 5 1 5
UTR 1702 1312 240 81 59 5 0 5
ncRNA 2273 1772 305 109 71 8 3 5
Intronic 13 308 10 328 1890 604 427 30 11 18
Upstream 230 175 32 7 9 1 0 6
Downstream 120 86 19 8 6 0 0 1
Regulatory 9 6 3 0 0 0 0 0
Intergenic 44 38 3 2 0 1 0 0
Total 25 431 20118 3344 1087 769 54 16 43
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The ratio of substitution rates at non-synonymous and synonymous
sites for all variants was 1.20; 1.57 for rare and 1.16 for low-frequency
variants and 0.86 for common variants. The dN/dS ratios revealed that
non-synonymous substitutions were prevalent in rare and low-
frequency variants, whereas the trend was reversed for common
variants. Consistent with purifying selection in large populations these
values were somewhat lower in UK10K-GS dataset: dN/dS= 1.11 for
all variants; and 1.38, 1.09 and 0.85 for rare, low frequency and
common variants, respectively. In line with this ﬁnding, median
inbreeding coefﬁcient FIT for major histocompatibility complex region
showed reduced heterozygosity in Vis: − 0.021, compared to UK10K-
GS: − 0.036.
The average genome-based kinship in Vis sample was low (0.002)
indicating that, as expected, unrelated individuals were selected in the
study. On the other hand, the average individual autozygosity in Vis
that was derived from long ROHs (45 Mb) was consistent with
second-cousin relationship, FROH45Mb 0.017, standard error of mean
(SEM) 0.004.14 Moreover, in comparison to UK10K-GS (FROH45Mb
0.001, SEM 0.0007), a signiﬁcantly higher proportions of individuals
with long ROHs were found in Vis (1 versus 11% in Vis, χ2,
P= 4.34× 10− 7). Median lengths per affected individual in Vis of
total and per segment ROH length were 10Mb (range, 7–35) and
9 Mb (7–22), respectively, whereas the corresponding values in
UK10K were 9 Mb (5–16) for both parameters.
Novel variants
We identiﬁed a total of 108 615 (37%) novel variants in the Vis exome
sequence data that were not present in UK10K-GS, 136 617 (47%)
novel variants not present in NHLBI, 114 176 (39%) novel variants
not present in ExAC, 60 345 (21%) novel variants not present in the
1000Genomes, 34 497 (12%) novel variants not present in dbSNP and
a total of 25 430 (9%) novel variants not present in any of the above
mentioned datasets (Supplementary Figure 5). The count of novel
variants by MAF for comparisons of Vis exome data with UK10K-GS,
NHLBI, ExAC, 1000Genomes and dbSNP (Supplementary Table 4)
clearly shows that the majority of novel variants belong to the rare
allele frequency spectrum (up to MAF 0.02).1 As expected, the greatest
number of singletons and doubletons are found in dbSNP (78%),
followed by comparison with ExAC (58%), then 1000Genomes (54%),
NHLBI (43%) and UK10K-GS (31%). A larger proportion of
common allele novel variants (~40% of all common variants) was
identiﬁed through comparisons with NHLBI or ExAC datasets as these
variants are mostly intronic (⩾69%) and are simply not present in
datasets, which are limited to exome sequence only. We can also see
that there are very few common novel variants identiﬁed through
comparison with 1000Genomes (0.01%) and dbSNP (0.001%), which
are databases with a very good capture of common variation
(Supplementary Table 4). Owing to the intronic regions within the
exome calling for the Vis sample, the largest effect category group of
novel variants in all ﬁve comparisons is intronic, followed by either
non-synonymous (UK10K-GS, 1000Genomes, dbSNP) or non-coding
RNA (NHLBI, ExAC) groups (Supplementary Figure 5). A detailed
presentation of the number of both summarised and the full set of
functional effects of novel variants by MAF can be found in
Supplementary material (Supplementary Tables 5 and 6;
Supplementary Figures 6 and 7).
A detailed view of the allele frequency/functional effect distributions
of completely novel variants (Table 1 and Figure 2) show that 79% of
these were singletons and an additional 17% were rare or low
frequency, highlighting the ability of WES to identify rare and low-
frequency variants. On the contrary, only 59 completely novel variants
Figure 2 Proportion of functional effects of completely novel variants by MAF.
Figure 1 Proportion of functional effects by allele frequency categories.
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(0.23%) were common suggesting that the discovery of a large number
of common novel variation through exome sequencing is highly
unlikely. Of completely novel variants, 52% were intronic, 18% were
non-synonymous, whereas percentages of non-coding RNA, synon-
ymous and UTR variants were comparable (from 7 to 9%) indicating
that in comparison to distribution of all variants, number of
completely novel synonymous variants is substantially decreased
(Figures 1 and 2).
Loss of function variants
The average number of LoF genotypes per genome in Vis and UK10K-
GS samples was 115 (range, 93–140) and 122 (96–149), respectively;
whereas the corresponding number of LoF variants in homozygous
state: 23 (15–34) and 24 (13–37), was comparable between
the datasets. On average, an individual in Vis had lower counts of
LoF genotypes by 6% (mean difference of 6.5 genotypes per genome,
95% CI: 5–8, P= 3.3 × 10− 16), LoF variants by 5% (7.7, 95% CI: 6–9,
P= 6.6 × 10− 16) and homozygous LoF variants by 5% (1.3, 95% CI:
0.6–2.0, P= 3.1× 10− 4) than in UK10K-GS.
In comparison to the dataset of high conﬁdence LoF SNVs
(n= 880) published by MacArthur et al.15, we identiﬁed 172 over-
lapping LoF SNVs in Vis and 227 in UK10K-GS dataset. Using only
these SNVs, the estimated number of potentially harmful LoF
genotypes per individual was 28 (17–39) in Vis and 29 (17–39) in
UK10K-GS, and the corresponding number of homozygous high
conﬁdence LoF variants was 5 (1–12) and 6 (0–14).
As expected, the largest proportion of LoF variants in Vis belonged
to the singleton category, whereas the proportions of doubleton, low
frequency and common variants were comparable (Supplementary
Figure 2a). Compared to LoF variants in UK10K_GS sample, there
was a depletion of LoF singletons (two-proportion z-test, P= 0.002),
overall rare LoF variants (P= 1× 10− 6) in Vis, and an excess of low
frequency (P= 1× 10− 5) and common variants (P= 0.016)
(Supplementary Figure 2b). A similar ﬁnding is observed when we
compared allele frequency distributions of all variants shared by the
two datasets or when we re-sampled the same number of individuals
from each population and compared distributions of shared LoF
variants.
Of the mapped genes containing LoF variants (n= 1451), 1355
and 786 genes were found in at least one GO-term category or one
pathway, respectively. Pathways that were signiﬁcantly over-
represented included 52 identiﬁed genes, of which the vast majority
were related to xenobiotic- (metabolization or activation; 27 genes or
52%) and/or to lipid metabolism (30 genes or 58%) (Table 2). The
Table 2 Genes with LoF variants— summary of predicted gene product function and location using gene ontology terms and pathway analysis
Pathway name Pathway source Total set size No. of identiﬁed genes P-value q-value Description
Over-represented pathwaysa
CYP2E1 reactions Reactome 11 6 (54.5%) 0.00004 0.0518 Xenobiotics related
Leukotriene metabolism EHMN 104 19 (18.3%) 9.89×10−5 0.0518 Lipid metabolism
Galactose metabolism KEGG 30 9 (30.0%) 0.000148 0.0518 Other
Tryptophan degradation INOH 66 14 (21.2%) 0.000158 0.0518 Xenobiotics relatedb
Metabolism of xenobiotics by cytochrome P450 KEGG 74 15 (20.3%) 0.000159 0.0518 Xenobiotics related
Androgen and oestrogen biosynthesis and metabolism EHMN 87 16 (18.4%) 0.000318 0.0789 Lipid metabolism
Fatty acids Reactome 15 6 (40.0%) 0.000339 0.0789 Lipid metabolism
Xenobiotics Reactome 21 7 (33.3%) 0.000398 0.0803 Xenobiotics related
Chemical carcinogenesis KEGG 81 15 (18.5%) 0.000448 0.0803 Xenobiotics related
C21-steroid hormone biosynthesis and metabolism EHMN 57 12 (21.1%) 0.000493 0.0803 Lipid metabolism
GO term Total set size No. of identiﬁed genes P-value q-value
Over-represented GO termsb
GO group: Molecular function
GO:0043167 ion binding 6117 531 (8.7%) 8.85×10−8 4.6×10−6
GO:0016787 hydrolase activity 2477 235 (9.5%) 3.66×10−6 9.51×10−5
GO:0016491 oxidoreductase activity 728 77 (10.6%) 0.000529 0.00917
GO:0019825 oxygen binding 47 9 (19.1%) 0.00601 0.071
GO:0030246 carbohydrate binding 279 32 (11.5%) 0.00683 0.071
GO:0004601 peroxidase activity 41 8 (19.5%) 0.00836 0.0724
GO group: Cellular compartment
GO:0005929 cilium 465 53 (11.4%) 0.000719 0.0302
GO:0044441 ciliary part 309 38 (12.3%) 0.000987 0.0302
GO:0005578 proteinaceous extracellular matrix 356 42 (11.9%) 0.00113 0.0302
GO:0034358 plasma lipoprotein particle 39 8 (20.5%) 0.00612 0.0926
GO:0005615 extracellular space 1338 120 (9.0%) 0.00686 0.0926
GO:0072562 blood microparticle 135 18 (13.4%) 0.00821 0.0926
GO:0032994 protein–lipid complex 41 8 (19.5%) 0.00836 0.0926
GO:0005604 basement membrane 97 14 (14.6%) 0.00926 0.0926
aAnnotations are ordered by q-values.
bTryptophan degradation pathway is classiﬁed as xenobiotic-related as tryptophan metabolites are known to activate aryl hydrocarbon receptor, transcription factor known to mediate most of the toxic
and carcinogenic effects of a wide variety of environmental contaminants.
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most signiﬁcant over-represented GO terms were: ion binding
(GO:0043167), hydrolase (GO:0016787) or oxidoreductase activity
(GO:0016491), with most genes assigned to these three categories
being associated with enzyme activity (61%).
We analysed in more detail a subclass of LoF variants exhibiting
high-MAF variability across Vis and the 1000Genomes Project super
populations. In total, we identiﬁed nine LoF variants belonging to this
subclass (Table 3). Unlike the majority of LoF variants that
are expected to be rare and to have limited geographic distribution,
the allele frequency of these variants ranged from rare to common
across different populations.
LoF variants in ROH regions
The distribution of LoF variants across an exome with respect to
ROH hotspots and coldspots regions has shown an increase in
frequency of LoF variants in hotspots, which was signiﬁcant at
α= 0.1 (OR 1.18, P= 0.083). The pathway and GO-term analyses of
genes containing the hotspot LoF variants have shown intriguing
results. Of the 92 mapped genes carrying a LoF variant in a ROH
hotspot region, 59% were assigned to over-represented GO terms, all
of which were exclusively membrane-related, either by the location,
or the membrane-related function or process (Table 4). Moreover,
with regard to processes or functions assigned to these terms,
as a rule they were included in some sort of cell’s response to either
internal or external signal. Similar was found with the pathway
analysis, which showed that of 48 mapped genes 53% belonged to
the over-represented pathways that were mainly related to cell’s
response to environmental signals, such as xenobiotics, odorant
molecules or allografts. Majority of identiﬁed genes in over-
represented families (76%) belonged to cytochrome P450 (CYP) or
solute-carrier (SLC) gene superfamilies, olfactory receptors (OR) or to
HLA gene family.
DISCUSSION
The purpose of this work was to provide a comprehensive insight into
the exomic structure of the isolated population of the Adriatic island
of Vis and to compare it with the UK10K-GS exome dataset, and with
reference databases (NHLBI, 1000Genomes, dbSNP and ExAC). Our
data support the ﬁndings that the population of Vis is a true genetic
isolate. In comparison with the UK10K-GS exomes, we see a depletion
of rare and an excess of low frequency and common variants, which is
suggesting that the population of Vis had undergone a bottleneck in
which the majority of rare variants have vanished but those that did
stay in the population have risen in frequency. We see there is a
burden of potentially deleterious variants in a low and common allele
frequency groups in Vis compared to UK10K-GS (Supplementary
Figure 2b). This is in line with several recent studies that identiﬁed an
excess of deleterious variants in the low-frequency range.16–20 Also, it
was already shown that there are more deleterious variants in
European than in African populations due to a long bottleneck effect
during out of Africa migrations.21 Finally, although only unrelated
individuals were included in our study, when Vis sample was
compared to the UK10K-GS sample, it had higher prevalence of
individuals affected with long ROH regions and had higher FROH45Mb
index. In fact, the value of FROH index in Vis was similar to the value
observed for unrelated sample of Orkney inbread population.14
Recent population genetics studies indicate that rapid growth
increases the load of rare variants22,23 and likely plays a role in the
Table 3 Putative LoF variants (n=9) with extremely high variability among populations: Vis and 1000Genomes super populations EUR, ASN,
AFR, AMR
Allele frequency in population
CHR Position (bp)a ID REF ALT Vis EUR AMR AFR ASN
Functional annotationb
Gene/regulatory element ID, functional annotation, number of transcripts;
1 27942176 rs2231879 T C 0.02 0.02 0.07 0.51 — Regulatory element ID: ENSR00001518649, regulatory_region_variant, –
Gene ID: FGR, splice_acceptor_variant, nc_transcript_variant, 1; intron_variant, 6
5 111481696 rs17134155 C T 0.18 0.18 0.13 0.52 0.05 Regulatory element ID: ENSR00001287518, regulatory_region_variant, –
Gene ID: EPB41L4A, splice_acceptor_variant, nc_transcript_variant, 1
6 139576544 rs41289819 G A 0.13 0.16 0.14 0.53 0.02 Gene ID: TXLNB, stop_gained:373:125, 1; intron_variant, 1
7 144364918 rs67644764 G T 0.06 0.05 0.11 0.61 0.002 Gene ID: TPK1, stop_gained:71:24, 1; intron_variant, NMD_transcript_variant, 2;
intron_variant, 3; intron_variant, nc_transcript_variant, 1; upstream_gene_variant, 2;
synonymous_variant, NMD_transcript_variant:129:43:L4L, 1; 5_prime_UTR_variant, 1
16 66861836 rs7195853 G A 0.05 0.07 0.09 0.56 0.03 Gene ID: NAE1 splice_donor_variant, NMD_transcript_variant, 1; intron_variant,
NMD_transcript_variant, 3; intron_variant, 8; intron_variant, nc_transcript_variant, 4;
16 90110950 rs1048149 C T 0.12 0.14 0.19 0.59 0.03 Regulatory element ID: ENSR00000512444, regulatory_region_variant, –
Gene ID: ENSG00000222019, stop_gained:68:23, 2; stop_gained,NMD_transcript_
variant:68:23, 1; non_coding_exon_variant, nc_transcript_variant, 1 Gene ID: GAS8,
3_prime_UTR_variant, NMD_transcript_variant, 1; 3_prime_UTR_variant, 1;
downstream_gene_variant, 5; non_coding_exon_variant,nc_transcript_variant, 1
17 72588806 rs545652 C A 0.11 0.14 0.19 0.52 0.04 Gene ID: C17orf77, stop_gained:621:207, 2; downstream_gene_variant, 1
Gene ID: CD300LD, upstream_gene_variant, 1
22 42336172 rs5758511 G A 0.25 0.27 0.20 0.03 0.51 Regulatory element ID: ENSR00000085774, regulatory_region_variant, –
Gene ID: CENPM stop_gained:7:3, 1; intron_variant, 5; downstream_gene_variant, 1
X 75004529 rs1343879 C A 0.02 0.03 0.24 0.05 0.91 Gene ID: MAGEE2, stop_gained:358:120, 1
aThe genomic reference sequence used is GRCh37/hg19. Population allele frequency of variants range from rare to common major allele.
bCalled with the Ensembl Variant Effect Predictor v2.8 against Ensembl 70.
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individual genetic burden.23 Furthermore, it was demonstrated in
a simulation study that population growth dramatically increases the
number of deleterious sites in the population and increases the
deleterious burden carried by each individual by ~ 6%.24 Following
these ﬁndings, one might expect that a population with slower
population growth may have a relatively smaller load of rare variants
and deleterious sites. Thus, the slightly lower average number of LoF
variant genotypes per Vis genome compared to UK10K-GS genome
could, at least in part, be due to limited population growth of the old
isolate on Vis,3 compared to the UK10K-GS population.
Estimates on average abundance of LoF genotypes per genome in
Vis (115) or UK10K-GS (122) were somewhat larger than the value of
110 estimated from the pilot phase of the 1000Genomes Project.25 The
pilot-phase value was based on a highly curated LoF variant list and
assessed around 100 LoF variants per individual with ~ 20 variants in
homozygous sites,15 suggesting slight over estimation of individual
number of LoF genotypes in our sample, possibly due to a less strict
ﬁltering procedure.
We detected a ~ 6% difference in the average per genome number
of LoF variant genotypes between Vis and UK10K-GS. This small
difference persisted (~6%) after singleton and doubleton variants
(those most affected by differences in sample size22 and also the most
abundant LoF variants) were removed in order to investigate the effect
of sample size differences on estimates of individual genetic burden in
Vis (n= 176) and UK10K-GS (n= 377).
Genes containing LoF variants in Vis were over-represented in
the xenobiotic- and lipid-metabolism pathways. Having in mind that
the identiﬁed lipid pathways are actually involved in the biosynthesis
of known endogenious xenobiotics (steroids, eicosanoids, fatty acids),
over-represented genes in Vis were almost entirely xenobiotic-related
suggesting that LoF mutations may be accumulating in genes
controlling the cell’s reaction to foreign molecules from the environ-
ment. The ﬁnding is in line with a most recent view that gene losses
are not necessarily evolutionary disadvantages, but can also contribute
to selective advantage in humans.26 In bacteria, in constant nutrient-
limited environment, LoF mutations have been shown to enhance
ﬁtness by disproportionately affecting enzymatic and regulatory
pathways,27 similar to what was found in our study. In addition,
over-represented genes found within ROH hotspot regions in Vis were
predominantly involved in some sort of external or internal signalling.
Table 4 Genes with LoF variants in ROH hotspots—summary of predicted-gene product function and location using gene ontology terms and
pathway analysis
Pathway name Pathway source Total set size No. of Identiﬁed genes P-value q-value Description
Over-represented pathwaysa
Allograft rejection Wikipathways 80 5 (6.2%) 2.21×10−5 0.00225 Immune response to allograft
Cytochrome P450—arranged by substrate type Reactome 61 4 (6.6%) 0.00013 0.00662 Xenobiotics metabolism
Phase 1—functionalization of compounds Reactome 79 4 (5.1%) 0.000353 0.00882 Xenobiotics metabolism
Olfactory signalling pathway Reactome 427 8 (1.9%) 0.000401 0.00882 Response to external signal
Warfarin pathway, pharmacokinetics PharmGKB 8 2 (25.0%) 0.000496 0.00882 Xenobiotics metabolism
Allograft rejection—Homo sapiens (human) KEGG 37 3 (8.1%) 0.000519 0.00882 Immune response to allograft
GO term Total set size
No. of identiﬁed
genes P-value q-value Description
Over-represented GO termsa
GO group: Cellular component
GO:0098805 whole membrane 1916 20 (1.0%) 0.000295 0.00534 Membrane location
GO:0098576 lumenal side of membrane 30 3 (10.3%) 0.000305 0.00534 Membrane location
GO:0098589 membrane region 1086 13 (1.2%) 0.00119 0.0138 Membrane location
GO:0005886 plasma membrane 4864 34 (0.7%) 0.00315 0.0276 Membrane location
GO:0071944 cell periphery 4967 34 (0.7%) 0.00453 0.0317 Membrane location
GO:0048475 coated membrane 88 3 (3.4%) 0.00756 0.0362 Membrane location
GO:0031300 intrinsic component of organelle membrane 271 5 (1.9%) 0.00781 0.0362 Membrane location
GO group: Molecular function
GO:0044459 plasma membrane part 2528 20 (0.8%) 0.00829 0.0362 Membrane location
GO:0005549 odorant binding 85 4 (4.7%) 0.000612 0.0134 Binding—external signal
GO:0003823 antigen binding 103 4 (4.0%) 0.00117 0.0134 Binding—external signal
GO:0004871 signal transducer activity 1663 16 (1.0%) 0.00296 0.0227 Response to internal/external signal
GO:0004872 receptor activity 1583 15 (1.0%) 0.00469 0.0269 Response to internal/external signal
GO group: Biological process
GO:0045321 leucocyte activation 701 10 (1.4%) 0.00123 0.0704 Response to internal/external signal
GO:0052192 movement in environment of other
organism involved in symbiotic interaction
84 3 (3.6%) 0.00665 0.099 Response to external signal
GO:0042221 response to chemical 4132 29 (0.7%) 0.0073 0.099 Response to external signal
GO:0002252 immune effector process 765 9 (1.2%) 0.00762 0.099 Response to internal/external signal
aAnnotations are ordered by q-values.
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The disruption of signalling networks responsible for regulating the
response to environmental changes was identiﬁed in yeast as the major
theme of adaptive evolution in constant environments.28 Whether the
same adaptive evolutionary process could also be used to explain
the evolution of Vis population given the constant physical (geography
and climate) and nutrient-limited environment should be investigated
further.
As the majority of LoF variants are rare and expected to have
very limited geographic distribution,29,30 we were particularly
interested in the subclass of putative LoF variants exhibiting
extremely high variability of allele frequency across populations,
ranging from rare to MAF. We identiﬁed nine LoF variants with
marked geographical differences which are, therefore, probable
targets of positive selection.31 Most of the variants were associated
with proteins involved in immune/defence response to pathogens
(FGR-regulator of immune response, CD300LD-immune receptor,
NAE1-a protooncogen involved in regulation of apoptosis,
CENPM-centromere protein which also encodes a human minor
histocompatibility antigen, GAS8-cytoskeletal linker, a putative
tumour suppressor also implicated in inﬂuenza virus release);
or proteins that are potential targets for pathogens to infect cells
(that is, glycosylated extracellular membrane proteins, such as
MAGEE2-a member of tumour speciﬁc antigen family and TXLNB
gene suspected of role in vesicle trafﬁc) (Table 3). In addition, four
(44%) of these nine variants were also assigned in the ENSEMBLE
GENE e72 database as ‘unclassiﬁed regulatory features’, that is,
regulatory variants that could be involved in gene transcription
regulation.
A primary purpose of this study was also to catalogue variants
that were not previously found in reference databases (UK10K-
GS, NHLBI, 1000Genomes and dbSNP). We found 9% of all
variants in Vis to be completely novel. Unsurprisingly, the
vast majority of completely novel variants were singletons, rare
or low frequency. The most common functional effect categories
were intronic variants, followed by non-synonymous and synon-
ymous. An interesting observation is that the number of SNVs
found in dbSNP (88%) was lower than anticipated for a European
sample.32 With most variants already catalogued in dbSNP and/or
by 1000Genomes, it is expected for a single European sample that
more than 90% of true variants are identiﬁed in the dbSNP
database.32 When we took into account the rate of completely
novel variants, that is, those not found in any of the four reference
datasets; the aggregate rate for known SNVs increased. Although
this lower rate could be due to false positive calls, the observed
Ti/Tv ratio was comparable to other WES studies (Supplementary
material). Alternatively, the somewhat lower dbSNP rate might
be a consequence of two main factors: background population and
demographic history. Our study samples were taken from
an isolated island population where we expect a drift up in
the frequency of rare variants unique to our sample, which
could result in increased proportion of detected novel variants.
Complete identiﬁcation of all human variants is one of the key
goals of modern genetics. This study represents a step forward in
this major challenge by providing a population-based catalogue of
variants and, importantly, identifying completely novel exomic
variants in the population isolate from the Adriatic island of Vis. It
also reveals the landscape of loss-of-function mutations that is
intriguing in terms of adaptive evolution. By providing a relatively
large set of variants not seen elsewhere, this study serves as a
valuable resource in understanding human variation, especially in
the light of genetic studies of human diseases, population genetics
and evolution in this population.
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